Why the study?
Does a multimarker approach improve the prediction of subsequent cardiac adverse events in patients with coronary artery disease compared to traditional risk factors?
Does a multimarker approach improve the prediction of subsequent cardiac adverse events in patients with coronary artery disease compared to traditional risk factors?
Answers are grounded in this paper and cite their sources.
A multimarker approach using canonical discriminant analysis improves the prediction of subsequent cardiac adverse events in patients with coronary artery disease.
< 0.001. By using the calculated discriminant equation with the weighted mean discriminant score (centroid), the sensitivity and specificity of our model were 79.4% and 74.3% in prediction of AE. These values were higher than that of the calculated C-statistics if traditional risk factors with/without biomarkers were used for AE prediction. In conclusion, canonical discriminant analysis of the multimarker approach is able to define the risk threshold at the individual patient level for personalized medicine.
No takes yet. Share an insight, caveat, or question.
Giurgea et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: